These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38962270)

  • 1. Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma.
    Yan W; Rao D; Fan F; Liang H; Zhang Z; Dong H
    Front Oncol; 2024; 14():1407434. PubMed ID: 38962270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
    Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma.
    Yang L; Zou T; Chen Y; Zhao Y; Wu X; Li M; Du F; Chen Y; Xiao Z; Shen J
    Hepatol Int; 2022 Aug; 16(4):741-754. PubMed ID: 35648301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
    Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
    Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.
    Tian Y; Yang W; Song J; Wu Y; Ni B
    Mol Cell Biol; 2013 Aug; 33(15):2810-6. PubMed ID: 23716588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.
    Rivière L; Quioc-Salomon B; Fallot G; Halgand B; Féray C; Buendia MA; Neuveut C
    Antiviral Res; 2019 Dec; 172():104618. PubMed ID: 31600532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted HBx gene editing by CRISPR/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells.
    Rawal P; Tripathi DM; Hemati H; Kumar J; Tyagi P; Sarin SK; Nain V; Kaur S
    Liver Int; 2024 Feb; 44(2):614-624. PubMed ID: 38105495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
    Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
    Front Immunol; 2021; 12():661204. PubMed ID: 33995383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding the multifaceted interventions between human sirtuin 2 and dynamic hepatitis B viral proteins to confirm their roles in HBV replication.
    Piracha ZZ; Saeed U; Piracha IE; Noor S; Noor E
    Front Cell Infect Microbiol; 2023; 13():1234903. PubMed ID: 38239506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
    Liu N; Jiao T; Huang Y; Liu W; Li Z; Ye X
    J Virol; 2015 Mar; 89(5):2739-49. PubMed ID: 25540364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
    Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
    World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X protein amplifies TGF-β promotion on HCC motility through down-regulating PPM1a.
    Liu Y; Xu Y; Ma H; Wang B; Xu L; Zhang H; Song X; Gao L; Liang X; Ma C
    Oncotarget; 2016 May; 7(22):33125-35. PubMed ID: 27121309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
    Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
    J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
    Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis.
    Jin XL; Hong SK; Kim H; Lee SK; Yi NJ; Lee KW; Suh KS
    Oncol Lett; 2019 Nov; 18(5):4984-4991. PubMed ID: 31612010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
    Kim ES; Zhou J; Zhang H; Marchetti A; van de Klundert M; Cai D; Yu X; Mitra B; Liu Y; Wang M; Protzer U; Guo H
    PLoS Pathog; 2022 Jun; 18(6):e1010576. PubMed ID: 35679251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Cell-Derived TGF-β Promotes Epithelial-Mesenchymal Transition via CD133 in HBx-Infected Hepatoma Cells.
    Rawal P; Siddiqui H; Hassan M; Choudhary MC; Tripathi DM; Nain V; Trehanpati N; Kaur S
    Front Oncol; 2019; 9():308. PubMed ID: 31069171
    [No Abstract]   [Full Text] [Related]  

  • 20. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
    Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.